COVID-19 patients have a high incidence of thrombosis, and thromboembolic complications
are associated with severe COVID-19 and high mortality. COVID-19 disease is associated …

In the broad range of human diseases, thrombo-inflammation appears as a clinical
manifestation. Clinically, it is well characterized in context of superficial thrombophlebitis that …

Adenosine is an endogenous nucleoside that regulates many physiological and
pathological processes. It is derived from either the intracellular or extracellular …

Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), is an emergent infectious disease that has caused millions of …

A proportion of people infected with SARS-CoV-2 develop moderate or severe COVID-19,
with an increased risk of thromboembolic complications. The inflammatory response to …

The COVID-19 Committee of the Lincei Academy has reviewed the scientific evidence
supporting the efficacy and safety of existing and new drugs/biologics for the preventing and …

Introduction COVID-19 is associated to an increased risk of thrombosis, as a result of a
complex process that involves the activation of vascular and circulating cells, the release of …

Severe acute respiratory syndrome coronavirus 2 infection affects not only the lungs, but
also the cardiovascular system, having a major impact on patients' outcomes. Myocardial …

The pathogenesis of coronavirus disease (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‑CoV‑2), is complex and involves dysregulated immune …

Dipyridamole (DIP) is a medication utilized to treat cardiovascular diseases, belonging to the
BCS II class of drugs with low solubility and high permeability. As the effectiveness of oral …